NASDAQ:DOMH

Dominari - DOMH Stock Forecast, Price & News

$3.36

+0.11 (+3.38%)

(As of 03/24/2023 12:00 AM ET)

Add

Compare

Today's Range: $3.28
▼
$3.37
50-Day Range: $2.98
▼
$4.45
52-Week Range: $2.88
▼
$10.20

Volume: 27,633 shs
Average Volume: 30,608 shs
Market Capitalization: $18.45 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Dominari (NASDAQ:DOMH) Stock

Dominari Holdings, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates a broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.

Receive DOMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dominari and its competitors with MarketBeat's FREE daily newsletter.

DOMH Stock News Headlines

March 26, 2023 | americanbankingnews.com

Dominari (DOMH) Scheduled to Post Quarterly Earnings on Monday

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive DOMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dominari and its competitors with MarketBeat's FREE daily newsletter.

DOMH Company Calendar

Today: 3/26/2023
Next Earnings (Estimated): 3/27/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial physical research
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:DOMH
CUSIP: N/A
CIK: 12239
Web: N/A
Phone: (112) 745-1374
Fax: 703-992-9348
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($3.8805)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-7,170,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -18.21%
Return on Assets: -16.94%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 29.54
Quick Ratio: 29.54

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $19.27 per share
Price / Book: 0.17

Miscellaneous

Outstanding Shares: 5,490,000
Free Float: 5,013,000
Market Cap: $18.45 million
Optionable: Not Optionable
Beta: 0.96

Key Executives

Anthony C. Hayes
Director, Chief Executive & Financial Officer

Christopher Devall
Chief Operating Officer

Darrell Dotson
Vice President-Drug Development & General Counsel

Key Competitors

View All Competitors

DOMH Stock - Frequently Asked Questions

How have DOMH shares performed in 2023?: Dominari's stock was trading at $3.28 at the beginning of the year. Since then, DOMH stock has increased by 2.4% and is now trading at $3.36.
View the best growth stocks for 2023 here.
When is Dominari's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, March 27th 2023.
View our DOMH earnings forecast.
What is Dominari's stock symbol?: Dominari trades on the NASDAQ under the ticker symbol "DOMH."

How do I buy shares of Dominari?: Shares of DOMH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Dominari's stock price today?: One share of DOMH stock can currently be purchased for approximately $3.36.
How much money does Dominari make?: Dominari (NASDAQ:DOMH) has a market capitalization of $18.45 million. The company earns $-7,170,000.00 in net income (profit) each year or ($3.8805) on an earnings per share basis.
How can I contact Dominari?: Dominari's mailing address is One Rockefeller Plaza, 11Th Floor, New York, New York 10020. The company can be reached via phone at (112) 745-1374, via email at investorrelations@aikidopharma.com, or via fax at 703-992-9348.

This page (NASDAQ:DOMH) was last updated on 3/26/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial